Anti-CD19 CAR T cell therapy promotes skin remodelling in systemic sclerosis

Nature Reviews Rheumatology · Published 2026-06-08 · DOI 10.1038/s41584-026-01396-0

Authors (1)

Holly Webster

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Webster, H. (2026). Anti-CD19 CAR T cell therapy promotes skin remodelling in systemic sclerosis. Nature Reviews Rheumatology. https://doi.org/10.1038/s41584-026-01396-0

Related articles

• Brepocitinib shows promise for dermatomyositis · Nature Reviews Rheumatology · 2026 · Same journal
• The gut–joint axis in osteoarthritis · Nature Reviews Rheumatology · 2026 · Same journal
• Progress made and the road ahead for cancer screening in myositis · Nature Reviews Rheumatology · 2026 · Same journal
• 20 years of progress in the classification of immune-mediated diseases · Nature Reviews Rheumatology · 2026 · Same journal
• The evolving comorbidity landscape of rheumatoid arthritis · Nature Reviews Rheumatology · 2026 · Same journal
• Decoding variants of uncertain significance in systemic autoinflammatory diseases · Nature Reviews Rheumatology · 2026 · Same journal
• Sex-dependent mechanisms in rheumatic diseases · Nature Reviews Rheumatology · 2026 · Same journal
• Rethinking early-stage knee osteoarthritis beyond radiography · Nature Reviews Rheumatology · 2026 · Same journal
• PD-1 agonism puts the brakes on pathogenic T cell responses in RA · Nature Reviews Rheumatology · 2026 · Same journal
• Sensory nerves protect against tendon degeneration · Nature Reviews Rheumatology · 2026 · Same journal